Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Decibel Therapeutics, Inc. | ck0001656536-ex322_7.htm |
| EX-31.2 - EX-31.2 - Decibel Therapeutics, Inc. | ck0001656536-ex312_8.htm |
| EX-31.1 - EX-31.1 - Decibel Therapeutics, Inc. | ck0001656536-ex311_9.htm |
| EX-23.1 - EX-23.1 - Decibel Therapeutics, Inc. | ck0001656536-ex231_351.htm |
| EX-4.3 - EX-4.3 - Decibel Therapeutics, Inc. | ck0001656536-ex43_350.htm |
| 10-K - 10-K - Decibel Therapeutics, Inc. | ck0001656536-10k_20201231.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Laurence Reid, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Annual Report on Form 10-K of Decibel Therapeutics, Inc. for the fiscal year ended December 31, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in such Form 10-K fairly presents, in all material respects, the financial condition and results of operations of Decibel Therapeutics, Inc.
|
|
|
/s/ Laurence Reid |
|
Laurence Reid, Ph.D. |
|
President and Chief Executive Officer |
|
(Principal Executive Officer) |
|
March 29, 2021 |